Basal Insulin Strategies Before Surgery

Ohio State University40 enrolled

Overview

Many patients with Type 2 Diabetes Mellitus (T2DM) are currently being managed with Basal Insulin (BI). However, there is little evidence to support guidelines on dosing adjustments in the preoperative period. The Society for Ambulatory Anesthesia does not advise a reduction in the dose of BI preoperatively, unless there is a specific history of hypoglycemia. The Endocrine Society suggests a 50% reduction in BI dose the evening before surgery. The authors hypothesized that a 25% reduction in BI dose the evening before surgery will result in better perioperative blood glucose control compared with our institutional 50% decrease.

A total of 40 subjects diagnosed with T2DM taking once-daily evening BI, scheduled to undergo elective surgery under general anesthesia will be consented and randomized in a 1:1 ratio to received either 50% or 25% reduction of their regular evening BI dose on the evening before surgery. Blood glucose levels (BGL) will be recorded perioperatively according to institutional guidelines.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Type2 Diabetes Mellitus

Interventions

25% reduction of basal insulin doseOTHER

Subjects will be instructed to reduce their basal insulin dose to 75% instead of our institutional 50%. Subject must check their own blood sugar before reporting to the hospital for their surgery. If the value is less than 70 or subjects are having symptoms of hypoglycemia, subjects will be instructed to immediately ingest 4-8 oz of fruit juice (without pulp) and call their doctor or the hospital.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who have volunteered and consented to participation in the study during their outpatient preoperative anesthesia appointment. * Type II Diabetics taking once-daily evening basal insulin (glargine or detemir) * Patients that will undergo general anesthesia * Patients who have been on basal insulin for ≥ 3months Exclusion Criteria: * Inability to read, comprehend, and sign informed consent * Patients with Type I Diabetes * Patients who take short-acting insulin boluses which make up greater than 20% of their total daily insulin dose * Patients who have been on chronic steroids ≥ 5 mg/dl prednisone daily or equivalent for ≥ 1 month within the past 12 months * Pregnant patients * Patients on twice-daily dosing of basal insulin * Patient who take basal insulin in the morning * Patients with a history of severe hypoglycemia, defined as any event in the previous year requiring assistance of another person to actively administer carbohydrate, glucagons, or other resuscitative actions * Patients that will undergo cardiac, transplant, or brain surgeries * Prisoners

Outcomes

Primary Outcomes

Pre-operative Fasting Blood Glucose, as Measured by Standardized Point of Care Capillary Blood Glucose (CBG) Device in the Pre-op Holding Area.

Capillary blood glucose before surgery, considering a fasting period up to 8 hours prior fasting blood glucose

Time frame: Hospital arrival - Anesthesia start time. The time period did not exceed 4 hours, considering that surgeries were scheduled to be morning cases.

Secondary Outcomes

Incidence of Preoperative Hypoglycemia

Capillary blood glucose level \<80 mg/dl

Time frame: Hospital arrival - Anesthesia start time. The time period did not exceed 4 hours, considering that surgeries were scheduled to be morning cases.

Incidence of Preoperative Hypoglycemia Requiring Ingestion of Juice Prior to Arrival to the Hospital

Capillary blood glucose level \<70 mg/dl

Time frame: Basal insulin dose administration the evening before surgery - Hospital arrival the morning of the surgery. The time period did not exceed 12 hours, considering a fasting period up to 8 hours and a preoperative period up to 4 hours.

Incidence of Preoperative Hyperglycemia

Capillary blood glucose level \>179 mg/dl

Time frame: Hospital arrival - Anesthesia start time. The time period did not exceed 4 hours, considering that surgeries were scheduled to be morning cases

Incidence of Intraoperative Hyperglycemia

Capillary or arterial/venous blood glucose level \>179 mg/dl

Time frame: Anesthesia start time - Anesthesia stop time. The time period did not exceed 10 hours, considering type of surgeries or procedures.

Incidence of Patients Requiring Initiation of Perioperative IV Insulin Drip

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.